205 related articles for article (PubMed ID: 2040345)
1. The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
Brodehl J
Eur J Pediatr; 1991 Apr; 150(6):380-7. PubMed ID: 2040345
[TBL] [Abstract][Full Text] [Related]
2. Conventional therapy for idiopathic nephrotic syndrome in children.
Brodehl J
Clin Nephrol; 1991; 35 Suppl 1():S8-15. PubMed ID: 1860269
[TBL] [Abstract][Full Text] [Related]
3. The treatment of minimal change nephrotic syndrome (lipoid nephrosis): cooperative studies of the Arbeitsgemeinschaft für Pädiatrische Nephrologie (APN).
Brodehl J; Krohn HP; Ehrich JH
Klin Padiatr; 1982; 194(3):162-5. PubMed ID: 6752557
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of chlorambucil in steroid-dependent and cyclophosphamide-resistant minimal change nephrotic syndrome.
Ueda N; Takahashi K; Akioka Y; Morooka M; Ogawa A; Tsuzuki K
J Nephrol; 2009; 22(5):610-5. PubMed ID: 19809993
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
Jones DP; Stapleton FB; Roy S; Wyatt RJ
Pediatr Nephrol; 1988 Jul; 2(3):291-5. PubMed ID: 3153028
[TBL] [Abstract][Full Text] [Related]
6. Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Kashtan C; Melvin T; Kim Y
Clin Nephrol; 1988 Feb; 29(2):79-85. PubMed ID: 3359697
[TBL] [Abstract][Full Text] [Related]
7. The Clinical Course of Minimal Change Nephrotic Syndrome With Onset in Adulthood or Late Adolescence: A Case Series.
Maas RJ; Deegens JK; Beukhof JR; Reichert LJ; Ten Dam MA; Beutler JJ; van den Wall Bake AWL; Rensma PL; Konings CJ; Geerse DA; Feith GW; Van Kuijk WH; Wetzels JF
Am J Kidney Dis; 2017 May; 69(5):637-646. PubMed ID: 28089478
[TBL] [Abstract][Full Text] [Related]
8. Treatment of nephrotic syndrome in children and controlled trials.
Filler G
Nephrol Dial Transplant; 2003 Aug; 18 Suppl 6():vi75-8. PubMed ID: 12953047
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Brodehl J; Brandis M; Helmchen U; Hoyer PF; Burghard R; Ehrich JH; Zimmerhackl RB; Klein W; Wonigeit K
Klin Wochenschr; 1988 Nov; 66(22):1126-37. PubMed ID: 3236762
[TBL] [Abstract][Full Text] [Related]
10. The treatment of relapse in adults with minimal change nephrotic syndrome: myths and facts.
Shigidi MM
Saudi J Kidney Dis Transpl; 2011 Jan; 22(1):10-7. PubMed ID: 21196608
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of the efficacy of cyclosporine A treatment in idiopathic nephrotic syndrome in children].
Wyszyńska T; Ksiazek J; Wieteska-Klimczak A; Gorzkowska-Paczwa M; Dorywalski T; Tysarowska A
Pol Merkur Lekarski; 2001 Aug; 11(62):140-3. PubMed ID: 11757213
[TBL] [Abstract][Full Text] [Related]
12. Case reports of low dose cyclosporine. A therapy in adult minimal change nephrotic syndrome.
Woo KT; Chew ST; Vathsala A; Chiang GS
Ann Acad Med Singap; 2001 Jul; 30(4):430-5. PubMed ID: 11503553
[TBL] [Abstract][Full Text] [Related]
13. Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome.
Tang S; Tang AW; Tam MK; Ho YW
Am J Kidney Dis; 2003 Nov; 42(5):E13-5. PubMed ID: 14582073
[TBL] [Abstract][Full Text] [Related]
14. Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
Ponticelli C; Passerini P
Clin Nephrol; 1991; 35 Suppl 1():S16-21. PubMed ID: 1860261
[TBL] [Abstract][Full Text] [Related]
15. [Management of idiopathic nephrotic syndrome in childhood].
Peco-Antić A
Srp Arh Celok Lek; 2004; 132(9-10):352-9. PubMed ID: 15794060
[TBL] [Abstract][Full Text] [Related]
16. Single-center experience with cyclosporine for treatment of idiopathic minimal change nephrotic syndrome in children.
Sabry A; El-Husseini A; El-Dahshan K; Sobh M
Iran J Kidney Dis; 2009 Jul; 3(3):127-35. PubMed ID: 19617660
[TBL] [Abstract][Full Text] [Related]
17. The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Dinçel N; Yılmaz E; Kaplan Bulut İ; Hacıkara Ş; Mir S
Ren Fail; 2015; 37(8):1267-72. PubMed ID: 26313331
[TBL] [Abstract][Full Text] [Related]
18. Cyclophosphamide in treatment of minimal change nephrotic syndrome.
Shohet I; Meyerovitch J; Aladjem M; Boichis H
Eur J Pediatr; 1988 Apr; 147(3):239-41. PubMed ID: 3391218
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of corticoid-resistant nephrotic syndrome: a still unresolved problem].
Damiani B; Giani M; Consalvo G; Carcano A; Ghio L; Edefonti A
Pediatr Med Chir; 1995; 17(1):9-15. PubMed ID: 7739938
[TBL] [Abstract][Full Text] [Related]
20. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome.
Nakayama M; Katafuchi R; Yanase T; Ikeda K; Tanaka H; Fujimi S
Am J Kidney Dis; 2002 Mar; 39(3):503-12. PubMed ID: 11877569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
